using tirzepatide and retatrutide together vs Tirzepatide: Best Triple Agonist Guide 2026 💉 Modern Weight Loss, Medically

Vegan, gluten-free, and delicious

In a 2023 Phase 2 trial published in the New England Journal of Medicine (Jastreboff et al.), retatrutide produced 22.8% to 24.2% mean weight loss at 48 weeks at the higher doses (8 to 12 mg)

DHS can be localized, presenting as erythematous, pruritic wheals and plaques at injection sites, or generalized

Here is how to think about it: What is normal during titration Mild nausea that comes and goes, especially in the first 35 days after a dose increase Reduced appetite this is the medication working as intended Occasional loose stools or minor constipation Mild fatigue or low energy as your caloric intake decreases Slight bloating or feeling full faster than usual These effects are typically self-limiting